T7: Explore your treatment options and give serious consideration to participation in clinical trials. #abcdrbchat

T6: A chemotherapeutic drug - eribulin - was approved last year b/c it improved survival in heavily pre-treated metastatic brca. #abcdrbchat

T5: Contralateral prophylactic mastectomy is most strongly considered for BRCA carriers (higher risk of a second breast cancer). #abcdrbchat

T4: All males diagnosed with breast cancer should consider genetic testing for BRCA1 / BRCA2. #abcdrbchat

T4: Formal counseling should go hand in hand with genetic testing for selected mutations related to hereditary breast cancer. #abcdrbchat

T3: High risk patients (e.g., mutation carriers) may need to consider breast MRI in conjunction with mammography for screening. #abcdrbchat

T3: Annual screening mammography should begin at age 40 for normal risk individuals. #abcdrbchat

T2: Risk reduction strategies include healthy living, exercise, and maintaining a normal body mass index. #abcdrbchat

T2: Early diagnosis through screening is still key. Prevention for high risk women can be achieved with medications or surgery. #abcdrbchat

T1: The majority of cases are sporadic. Less than 10% of cases are related to hereditary factors. #abcdrbchat

T1: One in 8 women are diagnosed with breast cancer. It is much more common in women, but men can be affected as well. #abcdrbchat

This is Minetta Liu, a breast medical oncologist from the Mayo Clinic in Rochester, MN. Thanks for letting me join today. #abcdrbchat